+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Comparison of FDG PET and double-phase sestamibi SPECT in the preoperative evaluation of primary hyperparathyroidism



Comparison of FDG PET and double-phase sestamibi SPECT in the preoperative evaluation of primary hyperparathyroidism



Journal of Nuclear Medicine 35(5 SUPPL ): 68P




(PDF emailed within 1 workday: $29.90)

Accession: 030630836

Download citation: RISBibTeXText


Related references

Preoperative ⁹⁹mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: comparison of SPECT-CT, SPECT, and planar imaging. Nuclear Medicine Communications 33(10): 1070-1076, 2013

Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism. Ajr. American Journal of Roentgenology 169(6): 1671-1674, 1997

Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery (St Louis) 131(2): 149-157, February, 2002

The cost-effectiveness of additional preoperative ultrasonography or sestamibi-SPECT in patients with primary hyperparathyroidism and negative findings on sestamibi scans. Archives of Otolaryngology--Head & Neck Surgery 132(1): 46-53, 2006

Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism. Journal of Nuclear Medicine 49(12): 2012-2017, 2008

Sestamibi SPECT/CT versus SPECT only for preoperative localization in primary hyperparathyroidism: a single institution 8-year analysis. Surgery, 2018

A Multimodal Imaging Protocol, (123)I/(99)Tc-Sestamibi, SPECT, and SPECT/CT, in Primary Hyperparathyroidism Adds Limited Benefit for Preoperative Localization. World Journal of Surgery 40(3): 589-594, 2016

Preliminary experience with double-phase SPECT using Tc-99m sestamibi in patients with hyperparathyroidism. Clinical Nuclear Medicine 22(4): 217-221, 1997

Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. Journal of Nuclear Medicine 37(11): 1809-1815, 1996

Preoperative technetium Tc 99m sestamibi SPECT imaging in the management of primary hyperparathyroidism in patients with concomitant multinodular goiter. Archives of Surgery 140(7): 656-660, 2005

Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism. Clinical Radiology 65(4): 278-287, 2010

Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT. Journal of Nuclear Medicine 38(6): 834-839, 1997

Comparison of 4D CT, ultrasonography, and 99mTc sestamibi SPECT/CT in localizing single-gland primary hyperparathyroidism. Otolaryngology--Head and Neck Surgery 152(3): 438-443, 2015

Early-phase technetium-99m sestamibi scintigraphy can improve preoperative localization in primary hyperparathyroidism. American Journal of Surgery 205(3): 269-73; Discussion 273, 2013

Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: a single-institution experience. Clinical Nuclear Medicine 37(3): 223-228, 2012